Skip to content

Clinical trials

Phase 4 Lymphoma trials in the United States

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Lymphoma Phase: Phase 4 Country / region: United States Clear all

10 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20021
20041
20051
20071
20131
20141
20221
20231
20261

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed6
Recruiting2
Active, not recruiting1
Terminated1

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Children's Hospital of Michigan1
Dana-Farber Cancer Institute1
H. Lee Moffitt Cancer Center and Research Institute1
Janssen Scientific Affairs, LLC1
M.D. Anderson Cancer Center1
Mt. Sinai Medical Center, Miami1
National Heart, Lung, and Blood Institute (NHLBI)1
Sanofi1
University of Maryland, Baltimore1
University of Miami1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Lymphoma10
Leukemia3
Neoplasms, Plasma Cell3
Leukemia, Lymphocytic, Chronic, B-Cell2
Myelodysplastic Syndromes2
Recurrence2
Waldenstrom Macroglobulinemia2
Anemia1
Blast Crisis1
Burkitt Lymphoma1

Trials

Showing 1 to 10 of 10. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.